We are live on ! Find out more
CELU icon

Celularity
CELU

29 hedge funds and large institutions have $156M invested in Celularity in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 2

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

71% more funds holding

Funds holding: 17 → 29 (+12)

48% more capital invested

Capital invested by funds: $105M → $156M (+$50.8M)

1.76% more ownership

Funds ownership: 3.67% → 5.43% (+1.8%)

Holders
29
Holders Change
+12
Holders Change %
+70.59%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
4
Reduced
1
Closed
2
Calls
$78K
Puts
–
Net Calls
+$78K
Net Calls Change
-$63K

Top Buyers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
+$11.9M
2
OCAM
Owl Creek Asset Management
New York
+$5.85M
3
KIM
Karpus Investment Management
New York
+$4.18M
4
CAC
Cowen and Company
New York
+$4.15M
5
Millennium Management
Millennium Management
New York
+$3.87M

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$6.96M
2
AA
AQR Arbitrage
Connecticut
-$5.96M
3
BCM
BlueCrest Capital Management
Jersey
-$4.97M

CELU Hedge Fund Activity: Q4 2019 in Review

29 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2019, worth a combined $156M — up 48% from $105M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new CELU positions and 2 closed out — a net gain of 12 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was HGC Investment Management, opening a new position worth an estimated $11.9M. The largest seller was Mangrove Partners, exiting entirely with an estimated $6.96M sold.

  • 29 institutional investors held Celularity (CELU) as of Q4 2019, up from 17 in Q3 2019.
  • Funds reported $156M of Celularity stock for Q4 2019, up 48% quarter-over-quarter.
  • 14 funds opened new Celularity positions in Q4 2019 and 2 closed out, a net change of +12 holders.
  • The largest Celularity buyer in Q4 2019 was HGC Investment Management, an estimated $11.9M added.
  • The largest Celularity seller in Q4 2019 was Mangrove Partners, an estimated $6.96M sold.

Based on aggregated 13F filings for Q4 2019.